login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
BIOAFFINITY TECHNOLOGIEW-27 (BIAFW) Stock News
USA
-
Nasdaq
- NASDAQ:BIAFW -
0.265
USD
-0.08 (-22.06%)
Last: 11/17/2025, 8:00:01 PM
Overview
Stock Chart
Technical Analysis
News
BIAFW Latest News, Press Relases and Analysis
All
Press Releases
8 days ago - By: bioAffinity Technologies, Inc.
- Mentions:
BIAF
bioAffinity Technologies Reports Third Quarter 2025 Financial Results
17 days ago - By: bioAffinity Technologies, Inc.
- Mentions:
BIAF
bioAffinity Technologies Reports Accelerating Month-Over-Month Growth in CyPath® Lung Test Volume
25 days ago - By: bioAffinity Technologies, Inc.
- Mentions:
BIAF
bioAffinity Technologies Announces Acceptance of Australian Patent Application for Platform to Detect and Characterize Multiple Lung Diseases
a month ago - By: bioAffinity Technologies, Inc.
- Mentions:
BIAF
bioAffinity Technologies Presents Research Supporting CyPath® Lung Processing Methods at CHEST 2025
a month ago - By: bioAffinity Technologies, Inc.
- Mentions:
BIAF
bioAffinity Technologies Announces Notification of Allowance for U.S. Patent Application for Its Diagnostic Algorithm and Test Method for Lung Cancer
a month ago - By: bioAffinity Technologies, Inc.
- Mentions:
BIAF
bioAffinity Technologies Regains Compliance with Nasdaq Listing Requirements
a month ago - By: bioAffinity Technologies, Inc.
- Mentions:
BIAF
bioAffinity Technologies, Inc. Announces Closing of $1.8 Million Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq Rules
a month ago - By: bioAffinity Technologies, Inc.
- Mentions:
BIAF
bioAffinity Technologies, Inc. Announces Approximately $1.8 Million Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq Rules
2 months ago - By: bioAffinity Technologies, Inc.
- Mentions:
BIAF
bioAffinity Technologies Reports Record Growth in CyPath® Lung Test Volume for Third Quarter 2025
2 months ago - By: bioAffinity Technologies, Inc.
- Mentions:
BIAF
bioAffinity Technologies Announces Closing of $4.8 Million Public Offering
2 months ago - By: bioAffinity Technologies, Inc.
- Mentions:
BIAF
bioAffinity Technologies Announces Pricing of $4.8 Million Public Offering
2 months ago - By: bioAffinity Technologies, Inc.
- Mentions:
BIAF
bioAffinity Technologies Adds to Growing Number of Case Studies Demonstrating Clinical Value of CyPath® Lung
2 months ago - By: bioAffinity Technologies, Inc.
- Mentions:
BIAF
bioAffinity Technologies Announces 1-for-30 Reverse Stock Split Effective at the Open of Trading on September 19, 2025
2 months ago - By: bioAffinity Technologies, Inc.
- Mentions:
BIAF
Case Study: CyPath® Lung Identifies Lung Cancer in Patient with Difficult-to-Diagnose Ground-Glass Pulmonary Nodules
3 months ago - By: bioAffinity Technologies
- Mentions:
BIAF
U.S. Medicine Magazine Spotlights CyPath® Lung as Promising Tool to Improve Lung Cancer Detection in Veterans, Lower Costs to the VA
3 months ago - By: bioAffinity Technologies, Inc.
- Mentions:
BIAF
bioAffinity Technologies Appoints New Members to Board of Directors
3 months ago - By: bioAffinity Technologies, Inc.
- Mentions:
BIAF
bioAffinity Technologies Announces Closing of Private Placement and Warrant Inducement Transaction for Approximately $1.2 Million in Gross Proceeds
3 months ago - By: bioAffinity Technologies, Inc.
- Mentions:
BIAF
bioAffinity Technologies Reports Second Quarter 2025 Results
3 months ago - By: bioAffinity Technologies, Inc.
- Mentions:
BIAF
bioAffinity Technologies Announces Pricing of Private Placement and Warrant Inducement Transaction for Approximately $1.2 Million in Gross Proceeds
3 months ago - By: bioAffinity Technologies, Inc.
- Mentions:
BIAF
bioAffinity Technologies Reports Accelerating Growth in CyPath® Lung Test Sales
4 months ago - By: bioAffinity Technologies, Inc.
- Mentions:
BIAF
Case Study: CyPath® Lung Detects Stage 1A Lung Cancer in High-Risk Patient With Inconclusive Imaging and Low-Risk Serum Test Results
4 months ago - By: bioAffinity Technologies, Inc.
- Mentions:
BIAF
Case Study: CyPath® Lung Detects Neuroendocrine Tumor Missed by Other Diagnostic Tools
4 months ago - By: bioAffinity Technologies, Inc.
- Mentions:
BIAF
Canada Awards New Patent to bioAffinity Technologies for CyPath® Lung, Company’s Noninvasive Lung Cancer Diagnostic
4 months ago - By: bioAffinity Technologies, Inc.
- Mentions:
BIAF
bioAffinity Technologies Announces Notification of China Patent Award for Company’s Noninvasive Lung Cancer Diagnostic
5 months ago - By: bioAffinity Technologies, Inc.
- Mentions:
BIAF
Case Study: CyPath® Lung Detects Stage 1A Lung Cancer in High-Risk Patient with Inconclusive Imaging
5 months ago - By: bioAffinity Technologies, Inc.
- Mentions:
BIAF
bioAffinity Technologies Scientists Present Breakthrough Cancer Research at RNA Therapeutics Conference
5 months ago - By: bioAffinity Technologies, Inc.
- Mentions:
BIAF
bioAffinity Technologies Expands Patent Portfolio with China Grant for siRNA-Based Cancer Therapy
5 months ago - By: bioAffinity Technologies, Inc.
- Mentions:
BIAF
bioAffinity Technologies President and CEO Maria Zannes Appointed to American Lung Association in Texas’ Leadership Board
6 months ago - By: bioAffinity Technologies, Inc.
- Mentions:
BIAF
bioAffinity Technologies Works With Cardinal Health™ OptiFreight® Logistics to Help Meet Demand for CyPath® Lung
6 months ago - By: bioAffinity Technologies, Inc.
- Mentions:
BIAF
bioAffinity Technologies Announces New U.S. Patent for Novel Broad Spectrum Cancer Therapeutics
6 months ago - By: bioAffinity Technologies, Inc.
- Mentions:
BIAF
bioAffinity Technologies Appoints Dr. Gordon Downie, MD, PhD, as Chief Medical Officer
6 months ago - By: bioAffinity Technologies, Inc.
- Mentions:
BIAF
bioAffinity Technologies Reports First Quarter 2025 Results
7 months ago - By: bioAffinity Technologies, Inc.
- Mentions:
BIAF
bioAffinity Technologies Announces Closing of $3.25 Million Offering
7 months ago - By: Yahoo Finance
- Mentions:
BABA
BIAF
DHI
CMG
...
BioAffinity Technologies announces pricing of $3.25M offering
7 months ago - By: Yahoo Finance
- Mentions:
UBS
ROK
TJX
BIAF
...
Rockwell Automation Lifts Full-Year Profit Outlook Following Second-Quarter Beat
7 months ago - By: bioAffinity Technologies, Inc.
- Mentions:
BIAF
bioAffinity Technologies Announces Pricing of $3.25 Million Offering
7 months ago - By: bioAffinity Technologies, Inc.
- Mentions:
BIAF
bioAffinity Technologies Increases Efficiency of CyPath® Lung Test by Boosting Data Acquisition Throughput by 50% and Reducing Unit Cost
8 months ago - By: Yahoo Finance
- Mentions:
GM
COMP
WAB
F
Veteran trader reminds investors of the market crashes through history
8 months ago - By: bioAffinity Technologies, Inc.
- Mentions:
BIAF
bioAffinity Technologies Reports Record $9.4 Million Revenue for 2024
8 months ago - By: bioAffinity Technologies, Inc.
- Mentions:
BIAF
Case Study: bioAffinity Technologies’ CyPath® Lung Detects Second Primary Lung Cancer in Patient With History of Lung Cancer
Please enable JavaScript to continue using this application.